CVS sues pharmacy benefit startup Capital Rx over ‘unenforceable’ non-compete clause

After Capital Rx’s former medical director of pharmacy services got a job offer at CVS, the PBM startup claimed he couldn’t work there because of a noncompete agreement. CVS recently sued the company, saying its non-compete clause was unenforceable.

Insights+ Key Biosimilars Events of August 2021

Biosimilars are developed to be highly similar versions of approved biologics in terms of safety, purity, and potency Biosimilars are expected to be a cost-effective alternative to the high-priced branded biologics, offering significant and much-needed cost savings to both payers and the patients During the month of August, Samsung Bioepis’ Byooviz (biosimilar, ranibizumab) received EC’s …

Insights+ Key Biosimilars Events of August 2021 Read More »

CVS joins the decentralized clinical trials movement with launch of new biz unit

CVS has launched a new clinical trials services business that will help drug companies and contract research organizations recruit clinical trial volunteers. The new business unit builds on work the pharmacy giant did last year, identifying and recruiting recruit people for clinical trials testing Covid-vaccines and medicines.

With telehealth, pharmacy offerings, Amazon starts to encroach on PBMs

As Amazon starts to roll out its telehealth and pharmacy offerings, most big health systems and insurers don’t yet view it as a threat. But pharmacy benefit managers and vertically integrated payers will be keeping a watchful eye on the company as it starts to encroach on a slice of their business. 

Pharmacies to start offering a limited number of Covid-19 vaccines

Walgreens, CVS, Walmart and dozens of other pharmacies will start administering a limited number of vaccines as part of the Federal Retail Pharmacy Program. It will offer vaccines in medically underserved areas to healthcare workers, people ages 65 and older, and essential workers, according to local guidelines.